West Pharmaceutical (WST) | Stock Overview & Key Data
West Pharmaceutical Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $475.35 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.07B Large-cap | 3.65% | 9.42% | 37.92% | 21.91% | 19.91% | 48.18% | -9.18% | -6.66% | 345.01% | 1,441.58% | 1,794.12% | |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
|
Alcon
ALC
|
45.84B Large-cap | 0.27% | 4.16% | -14.78% | -16.29% | -14.57% | -22.45% | -17.74% | -4.83% | 22.82% | 22.82% | 22.82% |
|
ResMed
RMD
|
32.03B Large-cap | -0.21% | -4.53% | -16.42% | -23.84% | -21.27% | -21.88% | -11.08% | -17.97% | 233.76% | 527.92% | 775.81% |
|
Hologic
HOLX
|
16.97B Large-cap | 0.56% | 0.56% | 1.40% | 12.23% | 1.94% | 31.39% | -9.66% | -0.85% | 110.15% | 246.29% | 206.74% |
Ownership & Short Interest
Calculate Your West Pharmaceutical Investment Returns
Long-Term Investment Performance Analysis
West Pharmaceutical stock price in Jul 2016 was $78.02, A $1,000.00 lump sum investment in West Pharmaceutical made 9 years ago would be worth approximately $4,248.01 today, representing a exceptional return of 324.80%. This translates to an annualized return (CAGR) of 15.72%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is WST's 52-week high and low?
- In the last 52 weeks, West Pharmaceutical reached a high of $336.82 (on June 9, 2026) and a low of $206.80 (on July 18, 2025).
- What is the market cap and P/E ratio for WST?
- Curious about West Pharmaceutical's size and valuation? Its market capitalization stands at 22.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is 40.99, and the forward P/E (looking ahead) is 32.05.
- Does WST pay dividends? If so, what's the yield?
- Yes, West Pharmaceutical is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.46%, and the company has paid an average of $0.82 per share annually over the past 3 years.
- Who are West Pharmaceutical's main competitors or similar companies to consider before investing?
When looking at West Pharmaceutical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -22.45% -17.74% ResMed
RMD32.03B Healthcare Medical Instruments & Supplies -21.88% -11.08% Hologic
HOLX16.97B Healthcare Medical Instruments & Supplies 31.39% -9.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for West Pharmaceutical Services Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of West Pharmaceutical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.13%, the Debt to Equity ratio from the most recent quarter is 10.73, and its Gross Profit Margin stands at 35.08%.
- What is the recent revenue and earnings growth for WST?
- Looking at West Pharmaceutical's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 21.00%, and quarterly earnings saw a YoY growth of 54.60%.
- How much of WST stock is held by insiders and institutions?
- Wondering who owns West Pharmaceutical stock? Company insiders (like executives and directors) hold about 0.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.21%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.